Moderna, Humana and Lumentum Hit 52-Week Highs
The three stocks reached fresh 52-week highs on Friday. Moderna and Humana shares rose 14% and 11%, respectively; the supplied report cites a planned NIH-backed cancer vaccine initiative, Humana’s Medicare Advantage ratings recovery and AI infrastructure demand.